Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 6/20 | 0.38 |
| ▸ | PPIB | P23284 | 1/20 | 0.32 |
| ▸ | PPIA | P62937 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19984870 | 1.00 | NFE2L2 (0.39) | NFE2L2PIN1PPIBPPIARAB9A | |
| SCHEMBL23877351 | 0.89 | NFE2L2 (0.40) | NFE2L2PIN1PPIBPPIAROCK1 | |
| SCHEMBL19984921 | 0.88 | NFE2L2 (0.39) | NFE2L2PIN1PPIBPPIAROCK1 | |
| SCHEMBL19984930 | 0.88 | NFE2L2 (0.39) | NFE2L2PIN1PPIBPPIAROCK1 | |
| SCHEMBL19984924 | 0.87 | PIN1 (0.41) | NFE2L2PIN1PPIBPPIAROCK1 | |
| SCHEMBL19984944 | 0.85 | NFE2L2 (0.38) | NFE2L2PIN1ROCK1 | |
| SCHEMBL21538698 | 0.84 | NFE2L2 (0.37) | NFE2L2PIN1PPIBPPIA | |
| SCHEMBL21538697 | 0.83 | PIN1 (0.37) | PIN1PPIBPPIARAB9A | |
| SCHEMBL21538751 | 0.79 | NFE2L2 (0.37) | NFE2L2CRBN | |
| SCHEMBL21538717 | 0.79 | NFE2L2 (0.36) | NFE2L2CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512843-B1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-20 | — | — | EP | disclosed |
| US-11136292-B2 | Plant growth regulator compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-05 | — | — | US | disclosed |
| US-20190330148-A1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-10-31 | — | — | US | disclosed |
| WO-2018050477-A1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | FGF1, MST1, CDC20 | NFE2L2 2365/4885PIN1 2117/4885PPIB 2189/4885 |
| US-20190330148-A1 | PLANT GROWTH REGULATOR COMPOUNDS | FGF1, MST1, CDC20 | NFE2L2 2365/4885PIN1 2117/4885PPIB 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.